Roche Holding AG (LON:0TDF)

Market Cap	217.28B
Revenue (ttm)	58.27B
Net Income (ttm)	8.65B
Shares Out	n/a
EPS (ttm)	10.78
PE Ratio	25.11
Forward PE	14.15
Dividend	0.67 (1.65%)
Ex-Dividend Date	Mar 28, 2025

Volume	100
Average Volume	21,112
Open	41.63
Previous Close	40.83
Day's Range	41.63 - 41.63
52-Week Range	34.39 - 45.75
Beta	n/a
RSI	45.89
Earnings Date	Oct 27, 2025

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagn...

• Industry: Pharmaceutical Preparations
• Founded: 1896
• Employees: 103,249
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0TDF

Financial Performance

In 2024, Roche Holding AG's revenue was 62.40 billion, an increase of 3.23% compared to the previous year's 60.44 billion. Earnings were 8.28 billion, a decrease of -28.01%.

Financial numbers in CHF